BTG plc - Product Pipeline Review - 2012
Summary
Global Market Direct’s pharmaceuticals report, “BTG plc - Product Pipeline Review - 2012” provides data on the BTG plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, BTG plc’s corporate website, SEC filings, investor presentations and featured press releases, both from BTG plc and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Reasons to buy
Keyword
Current R&D Portfolio of BTG plc; BTG plc - Key Therapeutics; BTG plc - Pipeline Overview and Promising Molecules; BTG plc - News; BTG plc - Latest Updates; BTG plc - Pipeline; BTG plc - Discontinued/Dormant Projects
Summary
Global Market Direct’s pharmaceuticals report, “BTG plc - Product Pipeline Review - 2012” provides data on the BTG plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, BTG plc’s corporate website, SEC filings, investor presentations and featured press releases, both from BTG plc and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- BTG plc - Brief BTG plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of BTG plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of BTG plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the BTG plc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate BTG plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of BTG plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the BTG plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with BTG plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of BTG plc and identify potential opportunities in those areas.
Keyword
Current R&D Portfolio of BTG plc; BTG plc - Key Therapeutics; BTG plc - Pipeline Overview and Promising Molecules; BTG plc - News; BTG plc - Latest Updates; BTG plc - Pipeline; BTG plc - Discontinued/Dormant Projects
BTG plc Snapshot
BTG plc Overview
Key Information
Key Facts
BTG plc – Research and Development Overview
Key Therapeutic Areas
BTG plc – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
BTG plc – Pipeline Products Glance
BTG plc – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
BTG plc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
BTG plc – Drug Profiles
Angiotensin Therapeutic Vaccine
Product Description
Mechanism of Action
R&D Progress
CoVaccine HT
Product Description
Mechanism of Action
R&D Progress
GLP-1 Peptide
Product Description
Mechanism of Action
R&D Progress
Varisolve
Product Description
Mechanism of Action
R&D Progress
BTG plc – Pipeline Analysis
BTG plc – Pipeline Products by Therapeutic Class
BTG plc – Pipeline Products By Target
BTG plc – Pipeline Products by Route of Administration
BTG plc – Pipeline Products By Mechanism of Action
BTG plc – Recent Pipeline Updates
BTG plc - Dormant Projects
BTG plc - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
BGC20-0166
BGC20-1259
BGC20-1531
BTG-6228
BTG6001
OncoGel
Prolarix
BTG plc – Company Statement
BTG plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
BTG plc - Key Manufacturing Facilities
BTG plc, Recent Developments
BTG plc- Press Release
Apr 23, 2012: BTG Announces Positive Results From Second US Pivotal Phase III Trial Of Varisolve
Mar 28, 2012: BTG Launches DigiFab In UK
Jan 30, 2012: BTG Announces Positive Data From First US Phase III Trial Of Varisolve
Jan 17, 2012: BTG Receives FDA Approval For Biologics License Application For Voraxaze
Financial Deals Landscape
BTG plc, Deals Summary
BTG plc, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Biocompatibles International Acquires Bead Technology Patents From BioCure
Biocompatibles International Completes Acquisition Of Cancer Diagnostic Products And Intellectual Property From Astron Clinica
BTG International Acquires Novel Opioid Agonist From CLL Pharma
BTG Acquires Novel Cellular Foetal DNA Diagnostic Technology From Professor Maj
Venture Financing
Xention Secures $13 Million In Series D Venture Financing
Xention Discovery Secures $3.4 Million In Series B Financing Round
Protez Pharma Secures Additional $6 Million In Series B Financing
Protez Pharma Secures $15 Million In Series B Financing
Xention Discovery Secures $19 Million In Series B Venture Financing
Avera Pharma Secures $48 Million In Series C Financing
Protez Pharma Secures $1.6 Million In Series A Financing
Partnerships
Bayer HealthCare Enters Into Licensing Agreement With DxS And BTG
Biocompatibles International Enters Into Licensing Agreement With Merz Pharma
BTG International Signs Licensing Agreement With Gambro
MedX Health Enters Into An Agreement With Biocompatibles International
BTG Enters Into Co-Marketing Agreement With Nycomed
IsoRay Enters Into Distribution Agreement With Biocompatibles International
Biocompatibles Enters Into Co-Development Agreement With AstraZeneca
PolyTherics Expands Co-Development Agreement With Biocompatibles
Terumo Europe Signs An Agreement With Biocompatibles International
Biocompatibles International Signs Agreement With SciClone Pharma
RITA Medical Systems Signs An Agreement With Biocompatibles International
BTG International Enters Into Collaboration Agreement With CamBP
BTG International Partners With Collegium Pharma
BTG International Signs Agreement With Collegium Pharma
Licensing Agreements
BTG International Signs Licensing Agreement With Cancer Research Technology And The Institute of Cancer Research
BTG Enters Into Licensing Agreement With Ohara Pharma For Glucarpidase
Ariel Pharma Enters Into Licensing Agreement With BTG International For AP-1531
BTG Enters Into Licensing Agreement With Wellstat Therapeutics For Uridine Triacetate
BTG Enters Into Licensing Agreement With Allergan
Eisai Enters Into Licensing Agreement With Biocompatibles International
BTG International Enters Into Licensing Agreement With Onyx Pharma
BTG Enters Into License Agreement With Novacea For AQ4N
BTG International Enters Into A Licensing Agreement With Fresenius Medical Care
SciClone Enteres Into Agreement With Biocomaptibles
BTG International Enters Into Licensing Agreement With Senexis
BTG International Enters Into Licensing Agreement With Asterand
BTG And DxS Amend Licensing Agreement With AstraZeneca
BTG International Enters Into Licensing Agreement With The University Of Illinois
Cougar Biotech Enters Into Licensing Agreement With BTG International
BTG And DxS Sign Licensing Agreement With AstraZeneca
Equity Offering
BTG International Completes Rights Offering For $50 Million
Asset Transactions
MedX Health To Acquire Siascopy Assets From BTG
BTG International Sells HySolv Drug Delivery Technology To Novartis Pharma
Alizyme Acquires COLAL Drug Delivery Technology From BTG
Victory Pharma Acquires Patent Estate From BTG
Abbott Labs Acquires Cardiovascular Stent Business Of Biocompatibles International
Acquisition
BTG International Acquires Biocompatibles
BTG International Acquires Protherics
Novartis Acquires Protez Pharma From BTG International
Biocompatibles Acquires CellMed
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
BTG plc, Key Information
BTG plc, Key Facts
BTG plc – Pipeline by Indication, 2012
BTG plc – Pipeline by Stage of Development, 2012
BTG plc – Monotherapy Products in Pipeline, 2012
BTG plc – Phase III, 2012
BTG plc – Phase II, 2012
BTG plc – Phase I, 2012
BTG plc – Pipeline By Therapeutic Class, 2012
BTG plc - Pipeline By Target, 2012
BTG plc – Pipeline By Route of Administration, 2012
BTG plc – Pipeline Products By Mechanism of Action, 2012
BTG plc – Recent Pipeline Updates, 2012
BTG plc - Dormant Developmental Projects,2012
BTG plc - Discontinued Pipeline Products, 2012
BTG plc, Other Locations
BTG plc, Subsidiaries
BTG plc, Key Manufacturing Facilities
BTG plc, Deals Summary
Biocompatibles International Acquires Bead Technology Patents From BioCure
Biocompatibles International Completes Acquisition Of Cancer Diagnostic Products And Intellectual Property From Astron Clinica
BTG International Acquires Novel Opioid Agonist From CLL Pharma
BTG Acquires Novel Cellular Foetal DNA Diagnostic Technology From Professor Maj
Xention Secures $13 Million In Series D Venture Financing
Xention Discovery Secures $3.4 Million In Series B Financing Round
Protez Pharma Secures Additional $6 Million In Series B Financing
Protez Pharma Secures $15 Million In Series B Financing
Xention Discovery Secures $19 Million In Series B Venture Financing
Avera Pharma Secures $48 Million In Series C Financing
Protez Pharma Secures $1.6 Million In Series A Financing
Bayer HealthCare Enters Into Licensing Agreement With DxS And BTG
Biocompatibles International Enters Into Licensing Agreement With Merz Pharma
BTG International Signs Licensing Agreement With Gambro
MedX Health Enters Into An Agreement With Biocompatibles International
BTG Enters Into Co-Marketing Agreement With Nycomed
IsoRay Enters Into Distribution Agreement With Biocompatibles International
Biocompatibles Enters Into Co-Development Agreement With AstraZeneca
PolyTherics Expands Co-Development Agreement With Biocompatibles
Terumo Europe Signs An Agreement With Biocompatibles International
Biocompatibles International Signs Agreement With SciClone Pharma
RITA Medical Systems Signs An Agreement With Biocompatibles International
BTG International Enters Into Collaboration Agreement With CamBP
BTG International Partners With Collegium Pharma
BTG International Signs Agreement With Collegium Pharma
BTG International Signs Licensing Agreement With Cancer Research Technology And The Institute of Cancer Research
BTG Enters Into Licensing Agreement With Ohara Pharma For Glucarpidase
Ariel Pharma Enters Into Licensing Agreement With BTG International For AP-1531
BTG Enters Into Licensing Agreement With Wellstat Therapeutics For Uridine Triacetate
BTG Enters Into Licensing Agreement With Allergan
Eisai Enters Into Licensing Agreement With Biocompatibles International
BTG International Enters Into Licensing Agreement With Onyx Pharma
BTG Enters Into License Agreement With Novacea For AQ4N
BTG International Enters Into A Licensing Agreement With Fresenius Medical Care
SciClone Enteres Into Agreement With Biocomaptibles
BTG International Enters Into Licensing Agreement With Senexis
BTG International Enters Into Licensing Agreement With Asterand
BTG And DxS Amend Licensing Agreement With AstraZeneca
BTG International Enters Into Licensing Agreement With The University Of Illinois
Cougar Biotech Enters Into Licensing Agreement With BTG International
BTG And DxS Sign Licensing Agreement With AstraZeneca
BTG International Completes Rights Offering For $50 Million
MedX Health To Acquire Siascopy Assets From BTG
BTG International Sells HySolv Drug Delivery Technology To Novartis Pharma
Alizyme Acquires COLAL Drug Delivery Technology From BTG
Victory Pharma Acquires Patent Estate From BTG
Abbott Labs Acquires Cardiovascular Stent Business Of Biocompatibles International
BTG International Acquires Biocompatibles
BTG International Acquires Protherics
Novartis Acquires Protez Pharma From BTG International
Biocompatibles Acquires CellMed
LIST OF FIGURES
BTG plc – Pipeline by Indication, 2012
BTG plc – Pipeline by Stage of Development, 2012
BTG plc – Monotherapy Products in Pipeline, 2012
BTG plc – Pipeline By Therapeutic Class, 2012
BTG plc – Pipeline By Route of Administration, 2012
BTG plc - Pipeline Products By Mechanism of Action, 2012
BTG plc Overview
Key Information
Key Facts
BTG plc – Research and Development Overview
Key Therapeutic Areas
BTG plc – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
BTG plc – Pipeline Products Glance
BTG plc – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
BTG plc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
BTG plc – Drug Profiles
Angiotensin Therapeutic Vaccine
Product Description
Mechanism of Action
R&D Progress
CoVaccine HT
Product Description
Mechanism of Action
R&D Progress
GLP-1 Peptide
Product Description
Mechanism of Action
R&D Progress
Varisolve
Product Description
Mechanism of Action
R&D Progress
BTG plc – Pipeline Analysis
BTG plc – Pipeline Products by Therapeutic Class
BTG plc – Pipeline Products By Target
BTG plc – Pipeline Products by Route of Administration
BTG plc – Pipeline Products By Mechanism of Action
BTG plc – Recent Pipeline Updates
BTG plc - Dormant Projects
BTG plc - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
BGC20-0166
BGC20-1259
BGC20-1531
BTG-6228
BTG6001
OncoGel
Prolarix
BTG plc – Company Statement
BTG plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
BTG plc - Key Manufacturing Facilities
BTG plc, Recent Developments
BTG plc- Press Release
Apr 23, 2012: BTG Announces Positive Results From Second US Pivotal Phase III Trial Of Varisolve
Mar 28, 2012: BTG Launches DigiFab In UK
Jan 30, 2012: BTG Announces Positive Data From First US Phase III Trial Of Varisolve
Jan 17, 2012: BTG Receives FDA Approval For Biologics License Application For Voraxaze
Financial Deals Landscape
BTG plc, Deals Summary
BTG plc, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Biocompatibles International Acquires Bead Technology Patents From BioCure
Biocompatibles International Completes Acquisition Of Cancer Diagnostic Products And Intellectual Property From Astron Clinica
BTG International Acquires Novel Opioid Agonist From CLL Pharma
BTG Acquires Novel Cellular Foetal DNA Diagnostic Technology From Professor Maj
Venture Financing
Xention Secures $13 Million In Series D Venture Financing
Xention Discovery Secures $3.4 Million In Series B Financing Round
Protez Pharma Secures Additional $6 Million In Series B Financing
Protez Pharma Secures $15 Million In Series B Financing
Xention Discovery Secures $19 Million In Series B Venture Financing
Avera Pharma Secures $48 Million In Series C Financing
Protez Pharma Secures $1.6 Million In Series A Financing
Partnerships
Bayer HealthCare Enters Into Licensing Agreement With DxS And BTG
Biocompatibles International Enters Into Licensing Agreement With Merz Pharma
BTG International Signs Licensing Agreement With Gambro
MedX Health Enters Into An Agreement With Biocompatibles International
BTG Enters Into Co-Marketing Agreement With Nycomed
IsoRay Enters Into Distribution Agreement With Biocompatibles International
Biocompatibles Enters Into Co-Development Agreement With AstraZeneca
PolyTherics Expands Co-Development Agreement With Biocompatibles
Terumo Europe Signs An Agreement With Biocompatibles International
Biocompatibles International Signs Agreement With SciClone Pharma
RITA Medical Systems Signs An Agreement With Biocompatibles International
BTG International Enters Into Collaboration Agreement With CamBP
BTG International Partners With Collegium Pharma
BTG International Signs Agreement With Collegium Pharma
Licensing Agreements
BTG International Signs Licensing Agreement With Cancer Research Technology And The Institute of Cancer Research
BTG Enters Into Licensing Agreement With Ohara Pharma For Glucarpidase
Ariel Pharma Enters Into Licensing Agreement With BTG International For AP-1531
BTG Enters Into Licensing Agreement With Wellstat Therapeutics For Uridine Triacetate
BTG Enters Into Licensing Agreement With Allergan
Eisai Enters Into Licensing Agreement With Biocompatibles International
BTG International Enters Into Licensing Agreement With Onyx Pharma
BTG Enters Into License Agreement With Novacea For AQ4N
BTG International Enters Into A Licensing Agreement With Fresenius Medical Care
SciClone Enteres Into Agreement With Biocomaptibles
BTG International Enters Into Licensing Agreement With Senexis
BTG International Enters Into Licensing Agreement With Asterand
BTG And DxS Amend Licensing Agreement With AstraZeneca
BTG International Enters Into Licensing Agreement With The University Of Illinois
Cougar Biotech Enters Into Licensing Agreement With BTG International
BTG And DxS Sign Licensing Agreement With AstraZeneca
Equity Offering
BTG International Completes Rights Offering For $50 Million
Asset Transactions
MedX Health To Acquire Siascopy Assets From BTG
BTG International Sells HySolv Drug Delivery Technology To Novartis Pharma
Alizyme Acquires COLAL Drug Delivery Technology From BTG
Victory Pharma Acquires Patent Estate From BTG
Abbott Labs Acquires Cardiovascular Stent Business Of Biocompatibles International
Acquisition
BTG International Acquires Biocompatibles
BTG International Acquires Protherics
Novartis Acquires Protez Pharma From BTG International
Biocompatibles Acquires CellMed
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
BTG plc, Key Information
BTG plc, Key Facts
BTG plc – Pipeline by Indication, 2012
BTG plc – Pipeline by Stage of Development, 2012
BTG plc – Monotherapy Products in Pipeline, 2012
BTG plc – Phase III, 2012
BTG plc – Phase II, 2012
BTG plc – Phase I, 2012
BTG plc – Pipeline By Therapeutic Class, 2012
BTG plc - Pipeline By Target, 2012
BTG plc – Pipeline By Route of Administration, 2012
BTG plc – Pipeline Products By Mechanism of Action, 2012
BTG plc – Recent Pipeline Updates, 2012
BTG plc - Dormant Developmental Projects,2012
BTG plc - Discontinued Pipeline Products, 2012
BTG plc, Other Locations
BTG plc, Subsidiaries
BTG plc, Key Manufacturing Facilities
BTG plc, Deals Summary
Biocompatibles International Acquires Bead Technology Patents From BioCure
Biocompatibles International Completes Acquisition Of Cancer Diagnostic Products And Intellectual Property From Astron Clinica
BTG International Acquires Novel Opioid Agonist From CLL Pharma
BTG Acquires Novel Cellular Foetal DNA Diagnostic Technology From Professor Maj
Xention Secures $13 Million In Series D Venture Financing
Xention Discovery Secures $3.4 Million In Series B Financing Round
Protez Pharma Secures Additional $6 Million In Series B Financing
Protez Pharma Secures $15 Million In Series B Financing
Xention Discovery Secures $19 Million In Series B Venture Financing
Avera Pharma Secures $48 Million In Series C Financing
Protez Pharma Secures $1.6 Million In Series A Financing
Bayer HealthCare Enters Into Licensing Agreement With DxS And BTG
Biocompatibles International Enters Into Licensing Agreement With Merz Pharma
BTG International Signs Licensing Agreement With Gambro
MedX Health Enters Into An Agreement With Biocompatibles International
BTG Enters Into Co-Marketing Agreement With Nycomed
IsoRay Enters Into Distribution Agreement With Biocompatibles International
Biocompatibles Enters Into Co-Development Agreement With AstraZeneca
PolyTherics Expands Co-Development Agreement With Biocompatibles
Terumo Europe Signs An Agreement With Biocompatibles International
Biocompatibles International Signs Agreement With SciClone Pharma
RITA Medical Systems Signs An Agreement With Biocompatibles International
BTG International Enters Into Collaboration Agreement With CamBP
BTG International Partners With Collegium Pharma
BTG International Signs Agreement With Collegium Pharma
BTG International Signs Licensing Agreement With Cancer Research Technology And The Institute of Cancer Research
BTG Enters Into Licensing Agreement With Ohara Pharma For Glucarpidase
Ariel Pharma Enters Into Licensing Agreement With BTG International For AP-1531
BTG Enters Into Licensing Agreement With Wellstat Therapeutics For Uridine Triacetate
BTG Enters Into Licensing Agreement With Allergan
Eisai Enters Into Licensing Agreement With Biocompatibles International
BTG International Enters Into Licensing Agreement With Onyx Pharma
BTG Enters Into License Agreement With Novacea For AQ4N
BTG International Enters Into A Licensing Agreement With Fresenius Medical Care
SciClone Enteres Into Agreement With Biocomaptibles
BTG International Enters Into Licensing Agreement With Senexis
BTG International Enters Into Licensing Agreement With Asterand
BTG And DxS Amend Licensing Agreement With AstraZeneca
BTG International Enters Into Licensing Agreement With The University Of Illinois
Cougar Biotech Enters Into Licensing Agreement With BTG International
BTG And DxS Sign Licensing Agreement With AstraZeneca
BTG International Completes Rights Offering For $50 Million
MedX Health To Acquire Siascopy Assets From BTG
BTG International Sells HySolv Drug Delivery Technology To Novartis Pharma
Alizyme Acquires COLAL Drug Delivery Technology From BTG
Victory Pharma Acquires Patent Estate From BTG
Abbott Labs Acquires Cardiovascular Stent Business Of Biocompatibles International
BTG International Acquires Biocompatibles
BTG International Acquires Protherics
Novartis Acquires Protez Pharma From BTG International
Biocompatibles Acquires CellMed
LIST OF FIGURES
BTG plc – Pipeline by Indication, 2012
BTG plc – Pipeline by Stage of Development, 2012
BTG plc – Monotherapy Products in Pipeline, 2012
BTG plc – Pipeline By Therapeutic Class, 2012
BTG plc – Pipeline By Route of Administration, 2012
BTG plc - Pipeline Products By Mechanism of Action, 2012
